SCI Pharmtech Inc (4119) — Cash Flow Reinvestment Rate
SCI Pharmtech Inc (4119) has a Cash Flow Reinvestment Rate of 2.91x as of March 2026, reinvesting NT$107.34 Million (capex NT$107.34 Million ) from operating cash flow of NT$36.89 Million. Check 4119 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SCI Pharmtech Inc Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for SCI Pharmtech Inc across 23 annual periods. Explore SCI Pharmtech Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for SCI Pharmtech Inc (2002–2025)
Year-by-year capital reinvestment analysis for SCI Pharmtech Inc. For live market cap and broader valuation context, see market value of SCI Pharmtech Inc.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.21x | NT$707.54 Million | NT$220.32 Million | NT$610.00 Million | ▲ +183.7% |
| 2024 | 1.13x | NT$974.05 Million | NT$860.52 Million | NT$946.64 Million | ▼ -87.1% |
| 2023 | 8.79x | NT$1.90 Billion | NT$215.77 Million | NT$1.03 Billion | ▲ +19.7% |
| 2022 | 7.34x | NT$2.18 Billion | NT$296.56 Million | NT$1.17 Billion | ▲ +103.2% |
| 2021 | 3.61x | NT$1.01 Billion | NT$280.28 Million | NT$774.98 Million | ▲ +706.1% |
| 2020 | 0.45x | NT$435.34 Million | NT$971.53 Million | NT$217.70 Million | ▲ +32.5% |
| 2019 | 0.34x | NT$267.76 Million | NT$791.60 Million | NT$204.49 Million | ▼ -21.2% |
| 2018 | 0.43x | NT$206.20 Million | NT$480.18 Million | NT$162.44 Million | ▼ -55.9% |
| 2017 | 0.97x | NT$273.96 Million | NT$281.65 Million | NT$147.39 Million | ▲ +16.8% |
| 2016 | 0.83x | NT$418.32 Million | NT$502.11 Million | NT$177.20 Million | ▲ +15.5% |
| 2015 | 0.72x | NT$478.51 Million | NT$663.24 Million | NT$217.51 Million | ▼ -44.0% |
| 2014 | 1.29x | NT$462.15 Million | NT$358.77 Million | NT$369.15 Million | ▼ -62.8% |
| 2013 | 3.46x | NT$826.27 Million | NT$238.57 Million | NT$773.01 Million | ▲ +638.2% |
| 2012 | 0.47x | NT$180.90 Million | NT$385.57 Million | NT$180.90 Million | ▼ -20.7% |
| 2011 | 0.59x | NT$147.71 Million | NT$249.55 Million | NT$147.71 Million | ▼ -31.9% |
| 2010 | 0.87x | NT$190.34 Million | NT$218.96 Million | NT$190.34 Million | ▲ +52.1% |
| 2009 | 0.57x | NT$181.13 Million | NT$316.96 Million | NT$181.13 Million | ▲ +1.5% |
| 2008 | 0.56x | NT$138.12 Million | NT$245.29 Million | NT$138.12 Million | ▼ -43.6% |
| 2007 | 1.00x | NT$167.21 Million | NT$167.53 Million | NT$167.21 Million | ▼ -18.9% |
| 2006 | 1.23x | NT$162.00 Million | NT$131.62 Million | NT$162.00 Million | ▲ +165.3% |
| 2004 | 0.46x | NT$35.55 Million | NT$76.61 Million | NT$35.55 Million | ▼ -4.3% |
| 2003 | 0.48x | NT$100.29 Million | NT$206.86 Million | NT$100.29 Million | ▲ +24.4% |
| 2002 | 0.39x | NT$41.73 Million | NT$107.12 Million | NT$41.73 Million | — |